Dana Genetic A/S: Financial statements 2017
CVR: 37298182
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
Dana Genetic A/S (CVR 37298182) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -341,751 and a net result of DKK -865,967. Equity in the 2017 report amounted to DKK -775,453.
- Gross Profit
- DKK -341,751
- Profit/Loss
- DKK -865,967
- Equity
- DKK -775,453
- Total Assets
- DKK 722,630
Official annual report
Keep an eye on Dana Genetic A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 25, 2017, Kurt Bækgaard Osther has left the board of directors of Dana Genetic A/S.
As of August 21, 2017, Joachim Osther has left the board of directors of Dana Genetic A/S.
As of April 20, 2017, Kurt Bækgaard Osther has joined the board of directors of Dana Genetic A/S.
As of April 20, 2017, Joachim Osther has joined the board of directors of Dana Genetic A/S.
As of April 20, 2017, Michael Lützhøft Hansen is registered as chairman of Dana Genetic A/S.
As of April 19, 2017, Kurt Bækgaard Osther has stepped down as chairman of Dana Genetic A/S.
Dana Genetic A/S has published its interim report for the period December 10, 2015 to September 30, 2016.
About Dana Genetic A/S
Dana Genetic A/S was a Danish company of the type Aktieselskab based in Gentofte, founded in 2015. The company has been dissolved on 14 February 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2021, the company reported a gross profit of DKK -46,878 and a net result of DKK 37,646 compared with DKK -474,616 the year before. Equity in the 2021 report amounted to DKK -2,578,564.